Exane Derivatives Nu Skin Enterprises, Inc. Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Nu Skin Enterprises, Inc. stock. As of the latest transaction made, Exane Derivatives holds 5 shares of NUS stock, worth $37. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$37
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NUS
# of Institutions
211Shares Held
41.6MCall Options Held
10.8KPut Options Held
77.5K-
Black Rock Inc. New York, NY8.12MShares$60.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$38 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.02MShares$15 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.83MShares$13.6 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.3MShares$9.65 Million0.0% of portfolio
About NU SKIN ENTERPRISES, INC.
- Ticker NUS
- Exchange NYSE
- Sector Consumer Defensive
- Industry Household & Personal Products
- Shares Outstandng 50,380,600
- Market Cap $375M
- Description
- Nu Skin Enterprises, Inc. develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products. The...